CLPT Expands Into Robotic System Supporting Cell and Gene Therapies
ClearPoint's new Robotic Neuro-Navigation System merges proven software with KUKA robotics to boost precision in cell and gene therapy delivery.
BRKR Shares Climb After Securing New Orders for Its NMR Systems
Bruker stock climbs after securing $10M in federally funded NMR orders from top U.S. research institutions.
ILMN Stock Set to Benefit From the Launch of New BioInsight Division
Illumina launches BioInsight to harness multiomic data, accelerate drug discovery, and boost disease diagnosis.
HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests
Hologic's shares rise after receiving FDA clearance and CE mark for its rapid molecular GI assays on the Panther Fusion platform.
ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves
AngioDynamics posts narrower-than-expected Q1 loss, 12% revenue growth and margin gains. it also raises FY26 sales outlook, sending shares higher.
Why Phibro Animal Health ( PAHC ) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
New Strong Buy Stocks for September 30th
UGP, PDS, FUTU, PAHC and PGY have been added to the Zacks Rank #1 (Strong Buy) List on September 30, 2025.
Bio-Techne Stock Climbs on Advances in Spatial Biology Solutions
TECH shares rise as advances in RNAscope and COMET spotlight new roles in lymphoid malignancy diagnostics.
Why Is Phibro ( PAHC ) Down 1.1% Since Last Earnings Report?
Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should Value Investors Buy Phibro Animal Health ( PAHC ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Growing Diagnostics Arm Supports ABT Stock, Macro Issues Ail
ABT gains momentum with strong FreeStyle Libre sales and Diagnostics growth but global macro headwinds weigh on performance.
National Vision Gains 166.5% in a Year: What's Driving the Rally?
EYE's 166.5% stock surge in a year is fueled by transformation efforts, partnerships, and strong growth in its Owned & Host segment.
Phibro Animal Health Stock Surges 82.1% YTD: What's Fueling It?
PAHC rallies 82% YTD with booming vaccines, MFAs and global expansion fueling investor confidence.
PAHC vs. BSX: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health ( PAHC Quick QuotePAHC - ) and Boston Scientific ( BSX Quick QuoteBSX - ) . But which of these two stocks offers value investors a better bang for their buck right now?
Medtronic Receives FDA Nod for Altaviva Device: Stock to Gain?
MDT gains FDA approval for its Altaviva device, a minimally invasive bladder control therapy with long-lasting benefits.
Is it a Prudent Move to Retain BSX Stock in Your Portfolio for Now?
Boston Scientific's acquisitions and WATCHMAN growth fuel optimism, but currency swings and macro pressures weigh on its outlook.
Reasons to Add Labcorp Stock to Your Portfolio Right Now
LH's biopharma lab growth and efficiency gains boost momentum, but currency and macro pressures weigh on its outlook.
Should You Hold STERIS Stock in Your Portfolio Right Now?
STE posts solid Healthcare and AST growth with strong liquidity but faces macroeconomic and currency headwinds.
Here's Why Phibro Animal Health ( PAHC ) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is Quest Diagnostics Stock a Right Pick for Your Portfolio Now?
DGX posts strong gains from physician and hospital channels while advancing AI-powered solutions.
3 Reasons Why Growth Investors Shouldn't Overlook Phibro ( PAHC )
Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Phibro Animal Health ( PAHC ) Is Up 0.43% in One Week: What You Should Know
Does Phibro Animal Health (PAHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Alcon sees growth from surgical innovation and vision care products, but faces macro pressures and fierce competition.
4 Best PEG-Based Value Stocks to Buy for Market-Beating Returns
Phibro, Daktronics, UP Fintech and Gold Fields stand out as PEG-based value picks with strong growth potential and solid fundamentals.
Is it the Right Time to Retain Abbott Stock in Your Portfolio?
ABT's strong Nutrition, Diabetes Care and EPD growth fuel momentum, but macro and currency headwinds challenge its outlook.
Alcon's UNITY VCS Shows Superior Efficiency in Studies, Stock Up
ALC's UNITY VCS shows faster, more efficient cataract and vitreoretinal surgery results, lifting shares after study presentations.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
LH Stock Rises on Acquisition of BioReference Health's Select Assets
Labcorp's $225M acquisition of BioReference Health select assets boosts its oncology diagnostics portfolio and expands patient access nationwide.
The New Olink Target 48 Neurodegeneration Panel May Boost TMO Stock
Thermo Fisher unveils the Olink Target 48 Neurodegeneration panel to accelerate biomarker research in neurodegenerative diseases.
Should You Continue to Hold Integra Stock in Your Portfolio Now?
IART shows strong demand in neurosurgery and Tissue Technologies but faces macro and liquidity challenges.
Is it a Prudent Move to Retain MYGN Stock in Your Portfolio Now?
Myriad Genetics expands oncology testing and launches new diagnostics, but inflation and rising competition weigh on its outlook.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
QGEN Stock Gains From CE-IVDR Certification for QIAstat-Dx Portfolio
QIAGEN secures CE-IVDR certification for its full QIAstat-Dx portfolio, boosting its diagnostics arm and lifting shares.
Exact Sciences Launches Cancerguard MCED Blood Test, Stock Climbs
EXAS introduces Cancerguard, a blood test that detects more than 50 cancers, sending shares up after its U.S. debut.
Should You Add IDEXX Stock to Your Portfolio Right Now?
IDXX shows strong CAG Diagnostics growth, cloud software momentum and global expansion but faces solvency and macro risks.
CRL Stock Rises Following New Strategic Oncology Collaborations
Charles River shares rise after new collaborations with PICI and CHLA, boosting its oncology and cell therapy pipeline momentum.
Here's Why You Should Add NVST Stock to Your Portfolio Right Now
Envista's global expansion, strategic acquisitions, and solid solvency boost growth outlook despite FX headwinds.
Should You Continue to Hold EXAS Stock in Your Portfolio?
Exact Sciences sees growth in Cologuard and Oncotype DX, but rising costs and tough competition weigh on EXAS shares.
Phibro Animal Health Corporation ( PAHC ) Hit a 52 Week High, Can the Run Continue?
Phibro (PAHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Are Investors Undervaluing Phibro Animal Health ( PAHC ) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why You Should Add PAHC Stock to Your Portfolio Right Now
Phibro Animal Health posts strong Animal Health sales growth, aided by a Zoetis acquisition, while Mineral Nutrition and Performance Products rebound.
ILMN Stock to Gain From the Launch of Illumina Protein Prep Assay
The Illumina Protein Prep rollout boosts multiomics, strengthens disease insights and supports ILMN stock momentum.
MYGN Stock Might Gain on The Lancet Study Backing Precise MRD
Myriad Genetics' Precise MRD study in The Lancet shows ctDNA detection power in oligometastatic ccRCC, supporting oncology growth plans.
MYGN's GeneSight Test Proven Superior to TAU: Stock to Gain?
Myriad Genetics' GeneSight test outperforms treatment-as-usual in major depression, raising hopes for broader adoption and renewed stock momentum.
MDT Stock May Benefit From New Regulatory Wins for Its MiniMed 780G
Medtronic secures FDA milestones for its MiniMed 780G system, expanding use to type 2 diabetes and enabling sensor integration.
Should You Hold Onto Globus Medical Stock in Your Portfolio for Now?
GMED rides strong musculoskeletal demand and new launches, but faces currency headwinds and fierce competition.
4 PEG-Rated GARP Stocks That Offer Both Value and Growth
Halozyme, Phibro, Leidos and PDD Holdings stand out as PEG-rated GARP picks, blending value and growth with solid long-term potential.
Is it the Right Time to Add CRL Stock to Your Portfolio Now?
Charles River's DSA growth, acquisitions and collaborations support momentum, but forex and macro headwinds weigh on its outlook.
Is Phibro ( PAHC ) a Solid Growth Stock? 3 Reasons to Think "Yes"
Phibro (PAHC) could produce exceptional returns because of its solid growth attributes.
QIAGEN Stock May Benefit From the US Clearance of QIAstat-Dx Rise
QGEN announces the launch of FDA-cleared QIAstat-Dx Rise, which may boost U.S. diagnostic access and testing capacity worldwide.
